As of 2024-12-14, the Fair Value of Enorama Pharma AB (ERMA.ST) is -3.86 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.10 SEK, the upside of Enorama Pharma AB is -224.54%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -23.80 | -23.46 | -27.74 | -42.03 | -44.61 | -32.33 |
| YoY growth | -45.65% | 1.44% | -18.27% | -51.50% | -6.15% | -24.03% |
| Market Cap (mil) | 166.24 |
| P/E | |
| Forward P/E |
| EPS | -0.77 |
| Avg earnings growth rate | -24.03% |
| TTM earnings | -41.41 |